Medicare to provide limited relief for biologic payment

Article

Amgen has gotten Medicare to pay for limited amounts of Enbrel, the $1,000-a-month rheumatoid-arthritis drug. The coverage, tucked in the new Medicare law that covers drugs for seniors, includes some expensive biotech drugs that patients can inject themselves, such as Enbrel and a rival, Abbott Laboratories' Humira.

Related Videos
Dr. Suneel Chilukuri
Health Care Impacts on Gender and Sexual Minority Patients
Caring for Gender and Sexual Minority Patients
Related Content

5 Ways to Negotiate the Best Physician Employment Contract

August 28th 2023

The Cutaneous Connection: Episode 18-Cybersecurity Within the Dermatology Practice

February 18th 2021

Disclosing Physician Health: What Is Required?

August 17th 2023

4 Key Tools to Protect Personal and Practice Assets

July 31st 2023

Expert Witness and Perjury

July 31st 2023

FDA Black Box Warning and Liability

June 30th 2023

5 Ways to Negotiate the Best Physician Employment Contract

August 28th 2023

The Cutaneous Connection: Episode 18-Cybersecurity Within the Dermatology Practice

February 18th 2021

Disclosing Physician Health: What Is Required?

August 17th 2023

4 Key Tools to Protect Personal and Practice Assets

July 31st 2023

Expert Witness and Perjury

July 31st 2023

FDA Black Box Warning and Liability

June 30th 2023

5 Ways to Negotiate the Best Physician Employment Contract

August 28th 2023

The Cutaneous Connection: Episode 18-Cybersecurity Within the Dermatology Practice

February 18th 2021

Disclosing Physician Health: What Is Required?

August 17th 2023

4 Key Tools to Protect Personal and Practice Assets

July 31st 2023

Expert Witness and Perjury

July 31st 2023

FDA Black Box Warning and Liability

June 30th 2023
© 2023 MJH Life Sciences

All rights reserved.